ArticleDrug safety2006
The Erice declaration : the critical role of communication in drug safety.
Article in Drug safety, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Article
- Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making.Drug safety · 2024Article
- Patients' perception of the pharmacovigilance system: A pre-diagnostic and post-interventional cross-sectional survey.Frontiers in pharmacology · 2022Article
- Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands.Drug safety · 2020Article
- Article
- Review
- Article
- Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance.Journal of pharmacology & pharmacotherapeutics · 2013Article
- Pattern and quality of scientific communications on drug safety produced by a regional pharmacovigilance center in Nepal.Pharmacy practice · 2010Article
- The good old drugs!Drug safety · 2009Article
- Pharmacovigilance: methods, recent developments and future perspectives.European journal of clinical pharmacology · 2008Review
- Intelligent risk communication: can it be improved?Drug safety · 2008Article
- Poisons centres and the reporting of adverse drug events: the case for further development.Drug safety · 2007Article
- Review
- Article
- Pharmacovigilance Programme of India: Recent developments and future perspectives.Indian journal of pharmacologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Erice Declaration on Communicating Drug Safety Information, first published in September 1997, provides a vision of vigorous, open, ethical, patient-centred communications in drug safety that the world has yet to achieve. The Declaration is reprinted here as a further stimulus to all parties to renew their commitment and to add new momentum to the improvements which have undoubtedly taken place in the past few years. The content of the Declaration is briefly reviewed, and some of the continuing communications challenges and problems are outlined.
Indexed as
Identifiers
16454537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.